See Tai Sandi 4
4 · Lexeo Therapeutics, Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
See Tai Sandi
Chief Development Officer
Transactions
- Sale
Common Stock
2025-02-19$4.41/sh−1,486$6,558→ 53,889 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 51,218 RSUs.